(Q51174629)

31 March 2018

review article

1 reference

title

The US Food and Drug Administration perspective on cancer biomarker development. (English)

1 reference

31 March 2018

0 references

Steven Gutman

1

1 reference

31 March 2018

Larry G Kessler

series ordinal

2

1 reference

31 March 2018

language of work or name

English

0 references

publication date

1 July 2006

1 reference

31 March 2018

published in

Nature Reviews Cancer

1 reference

31 March 2018

volume

6

1 reference

31 March 2018

page(s)

565-571

1 reference

31 March 2018

issue

7

1 reference

31 March 2018

https://scigraph.springernature.com/pub.10.1038/nrc1911

exact match

0 references

cites work

Realizing the promise of genomics in biomedical research

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy

21 January 2018

1 reference

New developments in the staging of melanoma

21 January 2018

1 reference

Spectrum bias: a quantitative and graphical analysis of the variability of medical diagnostic test performance

21 January 2018

1 reference

Operating characteristics of prostate-specific antigen and verification bias.

21 January 2018

1 reference

Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer

21 January 2018

1 reference

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

Translational crossroads for biomarkers

21 January 2018

1 reference

Biomarkers in cancer staging, prognosis and treatment selection

21 January 2018

1 reference

An assessment of Motorola CodeLink microarray performance for gene expression profiling applications

21 January 2018

1 reference

Microarray standard data set and figures of merit for comparing data processing methods and experiment designs

21 January 2018

1 reference

Clinical trial design for microarray predictive marker discovery and assessment

21 January 2018

1 reference

Multi-technique comparison of immobilized and hybridized oligonucleotide surface density on commercial amine-reactive microarray slides

21 January 2018

1 reference

A highly reproducible, linear, and automated sample preparation method for DNA microarrays

21 January 2018

1 reference

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.

21 January 2018

1 reference

"Sensitivity" and "specificity" reconsidered: the meaning of these terms in analytical and diagnostic settings

21 January 2018

1 reference

The discrepancy in discrepant analysis

21 January 2018

1 reference

REporting recommendations for tumour MARKer prognostic studies (REMARK)

21 January 2018

1 reference

Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer.

21 January 2018

1 reference

Sample size determination in microarray experiments for class comparison and prognostic classification.

21 January 2018

1 reference

Some statistical and regulatory issues in the evaluation of genetic and genomic tests

21 January 2018

1 reference

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

Pancreatic cancer: novel approaches to diagnosis and therapy

21 January 2018

1 reference

The STARD initiative and the reporting of studies of diagnostic accuracy

31 March 2020

1 reference

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1911

1 reference

31 March 2018

Dimensions Publication ID

0 references

1 reference

31 March 2018